UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcomes of Suspected Antibody-Mediated Rejection Post-Lung Transplantation

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S301-S302

2016

Volltextzugriff (PDF)

HLA-DQB-Matching Is Feasible and Does Not Prolong Wait Times for Lung Transplant Recipients

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S371-S371

2016

Volltextzugriff (PDF)

Early Downregulation of Innate NK Cell Reponses By Post-Transplant Blocking of VEGF Receptors Attenuates Experimental Obliterative Airway Disease in Mice

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S82-S83

2014

Volltextzugriff (PDF)

De Novo DQ Donor-Specific Antibodies Are Associated With Chronic Lung Allograft Dysfunction

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S98-S99

2014

Volltextzugriff (PDF)

Long-Term Results of Transplantation of Normothermic Ex-Vivo Perfused Donor Lungs

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S146-S147

2013

Volltextzugriff (PDF)

Identification of risk epitope mismatches associated with de novo donor‐specific HLA antibody development in cardiothoracic transplantation

American journal of transplantation, 2018-12, Vol.18 (12), p.2924-2933

2018

Volltextzugriff (PDF)

345: Blocking VEGF Receptors 1 and 2 Prevents Inflammatory Response and Experimental Obliterative Airway Disease

The Journal of heart and lung transplantation, 2010-02, Vol.29 (2), p.S116-S116

2010

Volltextzugriff (PDF)

341 VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease

The Journal of heart and lung transplantation, 2011, Vol.30 (4), p.S118-S118

2011

Volltextzugriff (PDF)

525: Role of Vascular Endothelial Growth Factor Receptors 1 and 2 in Experimental Obliterative Airway Disease

The Journal of heart and lung transplantation, 2009-02, Vol.28 (2), p.S248-S248

2009

Volltextzugriff (PDF)

329: Simvastatin Treatment Attenuates Obliterative Airway Disease Development in Rat Tracheal Allograft Model

The Journal of heart and lung transplantation, 2009-02, Vol.28 (2), p.S180-S180

2009

Volltextzugriff (PDF)

232: Simvastatin Treatment Inhibits the Development of Obliterative Airway Disease in Rat Tracheal Allografts

The Journal of heart and lung transplantation, 2008, Vol.27 (2), p.S144-S144

2008

Volltextzugriff (PDF)

29: Role of Vascular Endothelial Growth Factor-C in Experimental Obliterative Airway Disease

The Journal of heart and lung transplantation, 2008, Vol.27 (2), p.S70-S70

2008

Volltextzugriff (PDF)

426: Vascular endothelial growth factor-C enhances experimental obliterative bronchiolitis by inducing lymphangiogenesis

The Journal of heart and lung transplantation, 2007, Vol.26 (2), p.S213-S214

2007

Volltextzugriff (PDF)

Cytomegalovirus infection and cardiac allograft vasculopathy

Transplant infectious disease, 1999-06, Vol.1 (2), p.115-126

1999

Volltextzugriff (PDF)

(262) - Eosinophils on Transbronchial Biopsies Are Predictive of Reduced Survival After Lung Transplantation

The Journal of heart and lung transplantation, 2018-04, Vol.37 (4), p.S111-S111

2018

Volltextzugriff (PDF)

VEGF and PDGF have distinct roles in development of experimental obliterative bronchiolitis—a therapeutic approach

The Journal of heart and lung transplantation, 2005-02, Vol.24 (2), p.S142-S143

2005

Volltextzugriff (PDF)

335

The Journal of heart and lung transplantation, 2006-02, Vol.25 (2), p.S159

2006

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Plays a Major Role in Development of Experimental Obliterative Bronchiolitis

Transplantation proceedings, 2006-12, Vol.38 (10), p.3266-3267

2006

Volltextzugriff (PDF)

335: Vascular endothelial growth factor (VEGF) has a dual role in experimental obliterative bronchiolitis (OB)

The Journal of heart and lung transplantation, 2006, Vol.25 (2), p.S159-S159

2006

Volltextzugriff (PDF)

Inhibition of the receptor kinase activity of vegf and pdgf protects against the development of cardiac allograft arteriosclerosis

The Journal of heart and lung transplantation, 2004-02, Vol.23 (2), p.S124-S124

2004

Volltextzugriff (PDF)

132

The Journal of heart and lung transplantation, 2006-02, Vol.25 (2), p.S89-S90

2006

Volltextzugriff (PDF)

132: Interplay between inflammation and angiogenesis in cardiac allografts – therapeutic applications for VEGFR-1 and -2 inhibition

The Journal of heart and lung transplantation, 2006, Vol.25 (2), p.S89-S90

2006

Volltextzugriff (PDF)

Blockade of PDGF receptor protein-tyrosine kinase activity effectively inhibits development of rat CMV infection enhanced experimental obliterative bronchiolitis

The Journal of heart and lung transplantation, 2001-02, Vol.20 (2), p.167-167

2001

Volltextzugriff (PDF)

CD28/B7-2 pathway regulates the development of experimental obliterative bronchiolitis via promotion of TH1 cytokine expression

The Journal of heart and lung transplantation, 2001-02, Vol.20 (2), p.252-253

2001

Volltextzugriff (PDF)

CD28–B7-2 but not CD28–B7-1 interaction is required for T cell costimulation in experimental obliterative bronchiolitis in the rat

Transplantation proceedings, 2001-02, Vol.33 (1-2), p.535-535

2001

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Outcomes of Suspected Antibody-Mediated Rejection Post-Lung Transplantation

HLA-DQB-Matching Is Feasible and Does Not Prolong Wait Times for Lung Transplant Recipients

Early Downregulation of Innate NK Cell Reponses By Post-Transplant Blocking of VEGF Receptors Attenuates Experimental Obliterative Airway Disease in Mice

De Novo DQ Donor-Specific Antibodies Are Associated With Chronic Lung Allograft Dysfunction

Long-Term Results of Transplantation of Normothermic Ex-Vivo Perfused Donor Lungs

Identification of risk epitope mismatches associated with de novo donor‐specific HLA antibody development in cardiothoracic transplantation

345: Blocking VEGF Receptors 1 and 2 Prevents Inflammatory Response and Experimental Obliterative Airway Disease

341 VEGF-C/VEGFR-3 Signaling Regulates Inflammatory Response in Development of Obliterative Airway Disease

525: Role of Vascular Endothelial Growth Factor Receptors 1 and 2 in Experimental Obliterative Airway Disease

329: Simvastatin Treatment Attenuates Obliterative Airway Disease Development in Rat Tracheal Allograft Model

232: Simvastatin Treatment Inhibits the Development of Obliterative Airway Disease in Rat Tracheal Allografts

29: Role of Vascular Endothelial Growth Factor-C in Experimental Obliterative Airway Disease

426: Vascular endothelial growth factor-C enhances experimental obliterative bronchiolitis by inducing lymphangiogenesis

Cytomegalovirus infection and cardiac allograft vasculopathy

(262) - Eosinophils on Transbronchial Biopsies Are Predictive of Reduced Survival After Lung Transplantation

VEGF and PDGF have distinct roles in development of experimental obliterative bronchiolitis—a therapeutic approach

335

Vascular Endothelial Growth Factor Plays a Major Role in Development of Experimental Obliterative Bronchiolitis

335: Vascular endothelial growth factor (VEGF) has a dual role in experimental obliterative bronchiolitis (OB)

Inhibition of the receptor kinase activity of vegf and pdgf protects against the development of cardiac allograft arteriosclerosis

132

132: Interplay between inflammation and angiogenesis in cardiac allografts – therapeutic applications for VEGFR-1 and -2 inhibition

Blockade of PDGF receptor protein-tyrosine kinase activity effectively inhibits development of rat CMV infection enhanced experimental obliterative bronchiolitis

CD28/B7-2 pathway regulates the development of experimental obliterative bronchiolitis via promotion of TH1 cytokine expression

CD28–B7-2 but not CD28–B7-1 interaction is required for T cell costimulation in experimental obliterative bronchiolitis in the rat

Suchergebnisse filtern